Kolexia
Mas Emmanuel Pédiatrie
Mas Emmanuel
Pédiatrie
Hôpital Paule de Viguier
Toulouse, France
139 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies inflammatoires intestinales Mucoviscidose Inflammation Fibrose Colite Maladies gastro-intestinales Maladie de Crohn Malnutrition Rectocolite hémorragique

Collaborateurs

Voir plus
Breton Anne
Breton Anne
Hôpital Paule de Viguier, Toulouse, France
Peretti Noel
Peretti Noel
Hôpital Femme Mère Enfant, Bron, France
Tounian Patrick
Tounian Patrick
Hôpital Armand Trousseau, Paris, France
Olives Jean Pierre
Olives Jean Pierre
CHU Toulouse, Toulouse, France

Industries

Voir plus
Abbvie
12 collaboration(s)
Dernière en 2023
Biocodex
8 collaboration(s)
Dernière en 2022
Lilly
1 collaboration(s)
Dernière en 2023
Nestlé
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy: A Phase 2/3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
Essai Clinique (BMS)   11 mars 2024
RAPA-4-PAF: Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis.
Essai Clinique (CHU Toulouse)   08 mars 2024
Correction: Perinatal foodborne titanium dioxide exposure-mediated dysbiosis predisposes mice to develop colitis through life.
Particle and fibre toxicology   06 mars 2024
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis: A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis With an Inadequate Response to Conventional Therapy
Essai Clinique (BMS)   01 février 2024
BIODIGE: Intestinal Stem Cells Characterization in Intestinal Organoid Culture From Inflammatory Bowel Disease and Intestinal Polyposis Patients
Essai Clinique (CHU Toulouse)   02 janvier 2024
Treatment of pediatric heterozygous familial hypercholesterolemia: Where do we stand in real-world study in France seven years after the recommendations of the european atherosclerosis society (EAS)?
Clinical nutrition ESPEN   01 décembre 2023
Perinatal foodborne titanium dioxide exposure-mediated dysbiosis predisposes mice to develop colitis through life.
Particle and fibre toxicology   23 novembre 2023
Alimentation sans gluten : quelles indications chez l’enfant ?
Journal de pediatrie et de puericulture   05 octobre 2023
Accuracy of Serological Screening for the Diagnosis of Celiac Disease in Type 1 Diabetes Children.
Medicina (Kaunas, Lithuania)   18 juillet 2023
Nutrición enteral
EMC. Pediatria   01 juin 2023